DK237187A - PHARMACEUTICAL USE OF T-PA - Google Patents

PHARMACEUTICAL USE OF T-PA

Info

Publication number
DK237187A
DK237187A DK237187A DK237187A DK237187A DK 237187 A DK237187 A DK 237187A DK 237187 A DK237187 A DK 237187A DK 237187 A DK237187 A DK 237187A DK 237187 A DK237187 A DK 237187A
Authority
DK
Denmark
Prior art keywords
pharmaceutical use
pharmaceutical
Prior art date
Application number
DK237187A
Other languages
Danish (da)
Other versions
DK237187D0 (en
Inventor
Jr Henry Berger
Christ John Frangakis
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/862,057 external-priority patent/US4976959A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK237187D0 publication Critical patent/DK237187D0/en
Publication of DK237187A publication Critical patent/DK237187A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK237187A 1986-05-12 1987-05-11 PHARMACEUTICAL USE OF T-PA DK237187A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86204686A 1986-05-12 1986-05-12
US06/862,057 US4976959A (en) 1986-05-12 1986-05-12 T-PA and SOD in limiting tissue damage

Publications (2)

Publication Number Publication Date
DK237187D0 DK237187D0 (en) 1987-05-11
DK237187A true DK237187A (en) 1987-11-13

Family

ID=27127662

Family Applications (1)

Application Number Title Priority Date Filing Date
DK237187A DK237187A (en) 1986-05-12 1987-05-11 PHARMACEUTICAL USE OF T-PA

Country Status (13)

Country Link
JP (1) JPH0680015B2 (en)
AU (1) AU600724B2 (en)
BE (1) BE1001425A4 (en)
CH (1) CH672989A5 (en)
DE (1) DE3715662A1 (en)
DK (1) DK237187A (en)
FR (1) FR2600895B1 (en)
GB (1) GB2194886B (en)
IE (1) IE59895B1 (en)
LU (1) LU86875A1 (en)
NL (1) NL8701113A (en)
NZ (1) NZ220260A (en)
SE (1) SE8701921L (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780784B2 (en) * 1987-10-23 1995-08-30 宇部興産株式会社 Myocardial ischemic injury therapeutic agent based on microcirculatory disorder
NZ230808A (en) * 1988-10-24 1993-04-28 Squibb & Sons Inc Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent
DE4038563A1 (en) * 1990-12-04 1992-06-11 Gruenenthal Gmbh USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA
DE19518625C2 (en) * 1995-05-24 1997-08-07 Buescher Pebueso Beton Process for sealing concrete pipes and a concrete pipe suitable for carrying out the process
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7517529B2 (en) 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
AU2006266609C1 (en) 2005-07-05 2011-10-27 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US8652476B2 (en) 2009-07-27 2014-02-18 Niigata University Pharmaceutical composition for treating ischemic events
WO2011013668A1 (en) * 2009-07-27 2011-02-03 国立大学法人新潟大学 Pharmaceutical composition for treatment of ischemic events

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (en) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw NEW PLASMINOGEN ACTIVATOR AND PHARMACEUTICAL PREPARATION WITH THROMBOLYTIC ACTION.
DE3382389D1 (en) * 1982-12-14 1991-10-02 South African Inventions PLASMINOGEN ACTIVATOR.
JPS59196824A (en) * 1983-04-21 1984-11-08 Kowa Co Adsorption inhibitor
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
FR2593393B1 (en) * 1985-05-28 1989-06-02 Wellcome Found AQUEOUS SOLUTION FOR PARENTERAL USE OF PLASMINOGEN TISSUE ACTIVATOR, PROCESS FOR PREPARING THE SAME AND CONTAINER CONTAINING THE SAME
AU6334586A (en) * 1986-05-15 1987-12-01 Emory University Composition and method for treating a thrombus and embolus

Also Published As

Publication number Publication date
GB2194886A (en) 1988-03-23
DK237187D0 (en) 1987-05-11
NL8701113A (en) 1987-12-01
JPS6322026A (en) 1988-01-29
CH672989A5 (en) 1990-01-31
BE1001425A4 (en) 1989-10-31
SE8701921L (en) 1987-11-13
DE3715662A1 (en) 1987-11-19
AU7270487A (en) 1987-11-19
SE8701921D0 (en) 1987-05-11
FR2600895A1 (en) 1988-01-08
IE871210L (en) 1987-11-12
GB8711058D0 (en) 1987-06-17
JPH0680015B2 (en) 1994-10-12
GB2194886B (en) 1990-04-25
NZ220260A (en) 1990-07-26
FR2600895B1 (en) 1993-12-24
IE59895B1 (en) 1994-04-20
AU600724B2 (en) 1990-08-23
LU86875A1 (en) 1988-01-20

Similar Documents

Publication Publication Date Title
DK263288A (en) PHARMACEUTICAL PREPARATION OF CEFUROXIM-AXETIL
DK237187D0 (en) PHARMACEUTICAL USE OF T-PA
DK195988A (en) PHARMACEUTICAL PREPARATION CONTAINING MICROCASCAPES
DK149988A (en) STABLE PHARMACEUTICAL PREPARATIONS
DK363887D0 (en) USE OF BROMCRUPTIN
DK413987D0 (en) PHARMACEUTICAL PREPARATIONS
DK652787D0 (en) PHARMACEUTICAL PREPARATIONS
FR2598617B1 (en) PHARMACEUTICAL COMPOSITION
DK87888D0 (en) THERAPEUTIC USE OF TINDIODDEUTEROPORFYRIN
DK142487D0 (en) PHARMACEUTICAL AGENTS
DK447887A (en) PHARMACEUTICAL PREPARATIONS
DK564886D0 (en) FUNGICID USE OF TETRAHYDROBENZOTHIENYLURINE INGREDIENTS
DK517987D0 (en) CARTOGRAPHIC FITTING
DK127187A (en) PHARMACEUTICAL COMBINATION OF T-PA AND OXYPURINOL
DK541487D0 (en) SUMMARY OF MATERIALS
BR8606574A (en) GYROSCOPE
IT1231426B (en) PREPARATION OF POLYFLUOROENOLATES
DK453785D0 (en) GRF-EFFECTIVE MEDICINE
IT8847653A0 (en) SIZZANTE INCLUDING 5 - PHARMACEUTICAL HYDROSCOMPOSITION OF ANOREXYTRPOPHANE
BR8504188A (en) PREPARATION OF TERPINEN-4-OIS
DK149588D0 (en) XYLOMETAZOLE-CONTAINING PHARMACEUTICAL PREPARATIONS
SE8601446D0 (en) NOVEL PHARMACEUTICAL APPLICATIONS II
SE8503858D0 (en) NOVEL PHARMACEUTICAL APPLICATIONS
DK611887A (en) PHARMACEUTICAL MATERIALS
DK219786D0 (en) SYRINGE

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment